Journals / Acta Medica / 2019 / Cilt: 50 - Sayı: 2

Assessment of Molecular Mechanisms and Potential Biomarkers in Bladder Urothelial Carcinoma

Pages
8–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results of this study showed altered molecular mechanisms and increased our understanding of bladder urothelial carcinoma, proposed potential prognostic biomarkers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Bladder cancer ranks 10th among the most common cancers worldwide, effecting mostly man than women.
📊
Key Findings & Data:Results: Upregulated genes mainly annotated to cell cycle, p53 signaling and oocyte meiosis and maturation pathways and cell cycle related GO-BP terms.
💡
Conclusion & Impact:Conclusion: The results of this study showed altered molecular mechanisms and increased our understanding of bladder urothelial carcinoma, proposed potential prognostic biomarkers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Bladder cancer ranks 10th among the most common cancers worldwide, effecting mostly man than women. The aim of this study is to perform a detailed gene expression analysis of bladder urothelial carcino-ma to reveal altered molecular mechanisms and to find potential biomark-ers for this cancer. Materials and Methods: Bladder urothelial carcinoma RNA-seq data from TCGA with normal bladder samples from GTEx were analyzed by using GEPIA. Differentially expressed genes were annotated to GO-BP and KEGG pathway terms with DAVID and PPI networks were constructed by STRING. The association of upregulated cell cycle pathway proteins and patient sur-vival was further investigated. Results: Upregulated genes mainly annotated to cell cycle, p53 signaling and oocyte meiosis and maturation pathways and cell cycle related GO-BP terms. Downregulated genes mostly annotated to adhesion, ECM-receptor inter-action, vascular smooth muscle contraction and cardiomyopathy related KEGG pathways and muscle related GO-BP terms. The protein products of six cell cycle genes, which were upregulated in bladder urothelial carcinoma, showed significant association with patient survival. Conclusion: The results of this study showed altered molecular mechanisms and increased our understanding of bladder urothelial carcinoma, proposed potential prognostic biomarkers.

🔖

Cite This Article

SUCULARLI, C. (2019). Assessment of Molecular Mechanisms and Potential Biomarkers in Bladder Urothelial Carcinoma. Acta Medica, Cilt: 50 - Sayı: 2, 8–15. https://ajindex.com/articles/143130

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statis-tics 2018: GLOBOCAN estimates of incidence and mortali-ty worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
  2. Shinagare AB, Ramaiya NH, Jagannathan JP, et al. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol 2011; 196: 117-22.
  3. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 23 4 - 41. Zhang X, Zhang Y. Bladder Cancer and Genetic Mutations. Cell Biochem Biophys 2015; 73: 65-9.
  4. Tang F, He Z, Lei H, et al. Identification of differentially ex-pressed genes and biological pathways in bladder cancer. Mol Med Rep 2018; 17: 6425-34.[
  5. Di Y, Chen D, Yu W, et al. Bladder cancer stage-associat-ed hub genes revealed by WGCNA co-expression network analysis. Hereditas 2019; 156: 7. Yan M, Jing X, Liu Y, et al. Screening and identification of key biomarkers in bladder carcinoma: Evidence from bio-informatics analysis. Oncol Lett 2018; 16: 3092-100.
  6. Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 2017; 171: 540-56 e25. Choi W, Ochoa A, McConkey DJ, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017; 72: 354-65. Cancer Genome Atlas Research N. Comprehensive mo-lecular characterization of urothelial bladder carcinoma. Nature 2014; 507: 315-22.
  7. Glaser AP, Fantini D, Wang Y, et al. APOBEC-mediated mu-tagenesis in urothelial carcinoma is associated with im-proved survival, mutations in DNA damage response genes, and immune response. Oncotarget 2018; 9: 4537- 48. Gao JM, Huang LZ, Huang ZG, et al. Clinical value and po-tential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis. Oncol Lett 2018; 15: 5056-70.
  8. He RQ, Huang ZG, Li TY, et al. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update. Cell Physiol Biochem 2018; 50: 1474-95.
  9. Tang Z, Li C, Kang B, et al. GEPIA: a web server for can-cer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 2017; 45: W98-W102. Huang da W, Sherman BT, Lempicki RA. Bioinformatics en-richment tools: paths toward the comprehensive func-tional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
  10. Huang da W, Sherm